Cold & Cough Remedies (Pharmacies) - Tajikistan

  • Tajikistan
  • Revenue in the Cold & Cough Remedies market is projected to reach US$6.79m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 10.68%, resulting in a market volume of US$11.28m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.66 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Tajikistan is experiencing steady growth due to increasing customer preferences for over-the-counter remedies, along with local special circumstances and underlying macroeconomic factors.

Customer preferences:
In Tajikistan, there is a growing preference among customers for over-the-counter remedies for cold and cough. This can be attributed to several factors. Firstly, there is a general trend towards self-medication and home remedies, as people seek convenience and cost-effectiveness. Additionally, the increasing availability of a wide range of cold and cough remedies in pharmacies allows customers to choose products that best suit their needs. Customers also value the advice and recommendations provided by pharmacists, who play a crucial role in guiding them towards the right remedies.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Tajikistan is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients and potential side effects of pharmaceutical products, leading them to seek out natural alternatives. This trend is in line with the global shift towards natural and organic products, driven by growing health and wellness awareness. As a result, pharmacies in Tajikistan are stocking a wider range of natural and herbal remedies to cater to this demand. Another trend in the market is the rising popularity of combination remedies. Customers are looking for products that provide relief for multiple symptoms, such as cough, congestion, and sore throat, in a single dose. Combination remedies offer convenience and cost savings for customers, as they do not have to purchase multiple products. Pharmacies in Tajikistan are responding to this trend by stocking a variety of combination remedies, which are prominently displayed to attract customers.

Local special circumstances:
Tajikistan is a landlocked country in Central Asia, with a healthcare system that is still developing. Access to healthcare facilities, especially in rural areas, can be limited. As a result, people often rely on pharmacies for basic healthcare needs, including cold and cough remedies. Pharmacies serve as a convenient and accessible source of healthcare products and advice for the population. This reliance on pharmacies has contributed to the growth of the Cold & Cough Remedies market in Tajikistan.

Underlying macroeconomic factors:
Tajikistan has experienced steady economic growth in recent years, which has positively impacted the Cold & Cough Remedies market. As disposable incomes increase, people are willing to spend more on healthcare products, including over-the-counter remedies. Additionally, the government's focus on improving healthcare infrastructure and access to healthcare services has further contributed to the growth of the market. These macroeconomic factors create a favorable environment for the Cold & Cough Remedies market to thrive in Tajikistan. In conclusion, the Cold & Cough Remedies market in Tajikistan is developing due to increasing customer preferences for over-the-counter remedies, the trend towards natural and herbal products, the popularity of combination remedies, the reliance on pharmacies for healthcare needs, and the positive macroeconomic factors in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)